The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 350.00
Bid: 350.00
Ask: 355.00
Change: 10.00 (2.94%)
Spread: 5.00 (1.429%)
Open: 335.00
High: 350.00
Low: 335.00
Prev. Close: 340.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

6 Jul 2017 07:00

RNS Number : 2365K
Microgen PLC
06 July 2017
 

6 July 2017

 

MICROGEN plc ('Microgen' or 'Group')

 

TRADING UPDATE AND NOTICE OF RESULTS

 

 

Ahead of announcing Interim Results for the six months ended 30 June 2017 on 24 July 2017, Microgen (MCGN.L), a leading provider of business critical software and services, today issues the following update on trading for the financial year to date.

The Group has made excellent progress in the first half of 2017 resulting in a financial performance ahead of the Board's original expectations for the period whilst maintaining margins consistent with the prior year. The Group's two businesses are successfully executing their declared strategy with Aptitude Software delivering strong organic growth and Microgen Financial Systems successfully continuing on its transition towards a business focused on the Trust & Fund Administration ('T&FA') market.

A key highlight for the Group is the continued new business wins that have driven growth in Aptitude Software's recurring revenue base. Since 30 June 2016, the recurring revenue in Aptitude Software has increased 42% to £15.0 million as at 30 June 2017 (H1, 2016: £10.6 million and 31 December 2016: £12.6 million). There has also been exceptional growth in demand for Aptitude Software's implementation services in the first half of the year as a number of clients progress towards going live with the Aptitude Revenue Recognition Engine ('ARRE'). Upon completion of the half year the Board has reviewed the on-going demand for Aptitude Software's implementation services and, whilst clients' requirements continue to evolve, the Board is now confident that the exceptional level of demand experienced in the first six months of the year will continue throughout 2017, leading to a financial performance for the Group significantly ahead of the Board's expectations for the year. 

Opportunities for Aptitude's existing software and its new products provide the business with confidence for future years. Partners are becoming an increasingly important channel for new business, and as they provide a growing proportion of resources for new implementations, and as a number of the larger ARRE projects are completed, the exceptional level of demand for services experienced in 2017 is expected to moderate in 2018.

Microgen Financial Systems has maintained its focus on the T&FA market within the wealth management sector. The acquisition of Primacy Corporation in February 2017, a competitor in the T&FA market, represented the fifth acquisition since December 2014 and further strengthens the position of the business in this market. As a result of this focus T&FA revenues now represent approximately 60% of Microgen Financial Systems' H1 2017 revenue (H1, 2016: 51%), compared to 33% at the beginning of this transition in 2014.

 

Contacts

Ivan Martin, Chairman 020-7496-8100

Philip Wood, Chief Financial Officer

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUGMUPMGAA
Date   Source Headline
1st May 201410:28 amRNSTotal Voting Rights
28th Apr 201411:28 amRNSResult of AGM
28th Apr 20147:00 amRNSInterim Management Statement
16th Apr 20145:24 pmRNSDirector Declaration
7th Apr 201411:04 amRNSBlocklisting Interim Review
11th Mar 201411:29 amRNSPosting of Annual Report & AGM
26th Feb 20147:00 amRNSPreliminary Results
20th Feb 201410:25 amRNSNotice of Results
10th Feb 20144:24 pmRNSHolding(s) in Company
14th Jan 201410:14 amRNSHolding(s) in Company
3rd Jan 20143:56 pmRNSBlocklisting Interim Review
18th Dec 20135:14 pmRNSDirector/PDMR Shareholding
5th Dec 201310:33 amRNSHolding(s) in Company
4th Dec 20135:52 pmRNSHolding(s) in Company
4th Dec 20134:23 pmRNSHolding(s) in Company
4th Dec 20134:20 pmRNSHolding(s) in Company
4th Dec 20134:19 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSResult of Tender Offer
18th Nov 201311:52 amRNSResult of General Meeting
8th Nov 20132:13 pmRNSHolding(s) in Company
6th Nov 20134:49 pmRNSHolding(s) in Company
6th Nov 20134:46 pmRNSHolding(s) in Company
1st Nov 20131:31 pmRNSPosting of Shareholder Circular
29th Oct 20137:02 amRNSStrategic Review
29th Oct 20137:00 amRNSInterim Management Statement
28th Oct 20134:32 pmRNSHolding(s) in Company
23rd Oct 20131:01 pmRNSHolding(s) in Company
1st Oct 201312:51 pmRNSDirector Declaration
26th Sep 20132:26 pmRNSBlocklisting Interim Review
25th Sep 20134:32 pmRNSHolding(s) in Company
9th Aug 20137:00 amRNSDirectorate Change
22nd Jul 20137:00 amRNSInterim Results
17th Jul 20132:36 pmRNSHolding(s) in Company
15th Jul 20132:19 pmRNSNotice of Interim Results
2nd Jul 20133:16 pmRNSBlocklisting Return
1st Jul 201310:14 amRNSTotal Voting Rights
27th Jun 20131:57 pmRNSHolding(s) in Company
3rd Jun 20139:50 amRNSTotal Voting Rights
13th May 201311:53 amRNSResults of AGM
13th May 20137:00 amRNSInterim Management Statement
1st May 20137:00 amRNSTotal Voting Rights
29th Apr 20135:23 pmRNSHolding(s) in Company
29th Apr 20135:16 pmRNSHolding(s) in Company
9th Apr 201312:11 pmRNSHolding(s) in Company
8th Apr 20135:20 pmRNSHolding(s) in Company
5th Apr 20134:35 pmRNSHolding(s) in Company
2nd Apr 201310:58 amRNSTotal Voting Rights
25th Mar 20134:06 pmRNSBlocklisting Interim Review
21st Mar 20134:53 pmRNSAnnual Information Update
21st Mar 20133:33 pmRNSDirectors Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.